HomeMAZE • NASDAQ
add
Maze Therapeutics Inc
Previous close
$29.85
Day range
$28.74 - $31.23
Year range
$6.71 - $53.65
Market cap
1.44B USD
Avg Volume
952.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.06M | 28.03% |
Net income | -34.57M | -16.87% |
Net profit margin | — | — |
Earnings per share | -0.65 | — |
EBITDA | -37.56M | -29.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 341.92M | 73.73% |
Total assets | 397.13M | 65.10% |
Total liabilities | 42.16M | -3.38% |
Total equity | 354.97M | — |
Shares outstanding | 49.71M | — |
Price to book | 4.15 | — |
Return on assets | -23.23% | — |
Return on capital | -24.34% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -34.57M | -16.87% |
Cash from operations | -27.73M | -23.51% |
Cash from investing | -103.39M | -16,988.76% |
Cash from financing | 3.59M | -94.89% |
Net change in cash | -127.53M | -370.16% |
Free cash flow | -17.27M | -32.48% |
About
Founded
2017
Headquarters
Website
Employees
141
